This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

7 Stocks Hitting New 52-Week Highs

NEW YORK ( Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are hitting new 52-week highs and 52-week lows.

It often follows that a stock setting a new 52-week high will continue to set higher and higher highs (and the opposite for a stock setting a new 52-week low), and momentum traders often look to the 52-week-high lists for new stock ideas. Keep in mind, though, that new high prices can also indicate reasons for concern or caution in a stock.

Let's take a closer look at several stocks that hit new 52-week highs today.

>>5 Stocks Under $10 Set to Soar

El Paso (EP) operates in the natural gas transmission and exploration and production sectors of the energy industry. Its purpose is to provide natural gas and related energy products in a safe, efficient and dependable manner. It was recently trading up $4.70, or 24%, at $24.29 after hitting a 52-week high of $24.61 earlier in the day.

Today's Range: $23.40-$24.61

52-Week Range: $12.51-$24.61

Volume: 62 million

Ratings: Of 10 analysts covering the stock, all 10 rate it a buy. TheStreet Ratings' has a C+ hold rating on El Paso.

Kinder Morgan (KMI) has agreed to buy El Paso for $21.1 billion in cash and stock.

El Paso shows up in the portfolios of Leon Cooperman's Omega Advisors, with a new 4.2 million-share position initiated in the most recently reported quarter, and Daniel Loeb's Third Point, as the top holding with a 13 million-share position.

Anadys Pharmaceuticals (ANDS) is a biopharmaceutical company dedicated to improving patient care by developing novel medicines for the treatment of hepatitis C. It was recently trading up $2.61, or 251%, at $3.65 after hitting a 52-week high of $3.67 earlier in the day.

Today's Range: $3.64-3.67

52-Week Range: 60 cents-$3.67

Volume: 39.2 million

Ratings: Of 10 analysts covering the stock, seven rate it a buy, and three rate it a hold.

Anadys has ageed to be acquired by Swiss drugmaker Roche Holding for $230 million.

Anadys shows up on recent lists of 10 Hep C Stocks on Wall Street's Watch List and Stocks Under $5 Setting Up to Trade Higher.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,131.97 +100.83 0.59%
S&P 500 1,998.98 +14.85 0.75%
NASDAQ 4,552.7590 +33.8570 0.75%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs